TenCRAOS

Clinical Trial

NCT04526951 Active, Not recruiting

TenCRAOS

TENecteplase in Central Retinal Artery Occlusion Study (TenCRAOS): A Randomized Placebo-controlled Trial of Early Systemic Tenecteplase Treatment in Patients With Central Retinal Artery Occlusion.

Phase 3

Interventional

Disease

Disease type

Other

Patient type

Adult

Children

Inclusion / Exclusion

Opening date

30/10/2020

Closing date

28/02/2024

Inclusion criteria :

Exclusion criteria :

Funding

public

Members involved

Others investigators

Pr Michael LARSEN

Representative

Denmark

Neuro-Ophthalmology Rare Diseases (WG2), Research (TWG8), Retinal Rare Eye Diseases (WG1)

Working Group Leader

Dr Luc van Os

Substitute

Belgium

Pr Ingele Casteels

Representative

Belgium

Dr Dorte Ancher Larsen

Representative

Denmark

Dr Joni Turunen

Representative

Finland

Genetic Diagnostics (TWG6), Pediatric Ophthalmology Rare Diseases (WG3), Research (TWG8)

Dr David KEEGAN

Representative

Ireland

Working Group Leader

Prof Reda ZEMAITIENE

Representative

Lithuania

Anterior Segment Rare Eye Diseases (WG4), National Integration (TWG9), Pediatric Ophthalmology Rare Diseases (WG3)

Pr Stefan Löfgren

Representative

Sweden

Low Vision Daily Life and Patients Groups (TWG5), National Integration (TWG9), Pediatric Ophthalmology Rare Diseases (WG3), Registries & Epidemiology (TWG7)